GOURI (1x1ml)

GOURI

Collagen biostimulator – injectable implant

Fully solubilized liquid polycaprolactone (PCL) collagen inducer for facial rejuvenation

CE Marked injectable medical device based on fully solubilized polycaprolactone (PCL), classified under medical Device regulations in the EU/EEA.
Developed using DEXLEVO’s patented CESABP (Collagen Enabled Solubilized Active Biodegradable Polymer) technology, which enables microparticle Free liquid PCL for dermal injection.
Manufactured in facilities operating under medical Device quality management systems (e.g., ISO 13485) as reported in manufacturer and distributor documentation.

CE Marked injectable medical device based on fully solubilized polycaprolactone (PCL), classified under medical Device regulations in the EU/EEA.
Developed using DEXLEVO’s patented CESABP (Collagen Enabled Solubilized Active Biodegradable Polymer) technology, which enables microparticle Free liquid PCL for dermal injection.
Manufactured in facilities operating under medical Device quality management systems (e.g., ISO 13485) as reported in manufacturer and distributor documentation.
Distributed to licensed medical professionals in compliance with local regulations governing injectable aesthetic medical devices.

Description

GOURI (1x1ml) is the world’s first fully solubilized liquid collagen-inducing polycaprolactone (PCL) injectable, developed by DEXLEVO Inc. using its patented CESABP (Collagen Enabled Solubilized Active Biodegradable Polymer) technology. As a fully liquid, particle-free PCL implant, GOURI spreads homogeneously in the deep dermis after injection and stimulates natural neocollagenesis to improve skin structure, elasticity and facial contours. Designed exclusively for medical aesthetic practitioners, it provides pan-facial, gradual and natural rejuvenation without the immediate bulk or “filler” look, positioning it as a premium regenerative aesthetic medicine solution.

Bnefits

World’s first fully solubilized liquid PCL collagen inducer, offering a unique, particle-free biostimulatory approach.
Patented CESABP technology ensures a homogeneous, stable, fluid solution that diffuses evenly through dermal tissues.
Stimulates endogenous collagen production (neocollagenesis) to improve skin firmness, elasticity, texture and dermal density.
Delivers natural, progressive rejuvenation without creating an artificial volumising or overfilled appearance.
Enables comprehensive facial treatment with a reduced number of injection points due to high spreadability within the deep dermis.
Provides long-lasting results, with collagen-induced improvements that can persist for many months after treatment.
Liquid formulation without microparticles reduces the risk of nodule formation associated with particulate biostimulators.
Premium positioning in regenerative aesthetic medicine, suitable for patients seeking global skin-quality enhancement rather than focal volume.
CE-marked medical device manufactured under dedicated medical-device quality systems.

Indications

Stimulation of collagen production for global facial rejuvenation in adults with mild to moderate skin laxity.
Improvement of skin structure, elasticity and firmness across the face via neocollagenesis.
Enhancement of natural facial contours and dermal density without immediate volumising filler effect.
Preventative collagen-stimulation strategies in patients beginning to show early signs of ageing who wish to maintain skin quality.